The knowledge regarding screening services for prostate cancer was relatively low, as only less than a quarter of respondents reported having prior knowledge about PSA (prostate-specific antigen) testing, and as high as (64.1%) of respondents had no idea that PSA and DRE testing are used to detect prostate cancer. Here, KLK3 is linked to prostate carcinoma.